Adverse events associated with the gold probe and the injection gold probe devices used for endoscopic hemostasis: A MAUDE database analysis

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 1

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Endoscopy

ISSN

1948-5190

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Gastrointest Endosc. Jan 16, 2024; 16(1): 37-43
Published online Jan 16, 2024. doi: 10.4253/wjge.v16.i1.37

Table 7 Reports by year (2013-2023)

Year	MAUDE reports for gold probe	MAUDE reports for injection gold probe
2013	32	38
2014	32	36
2015	17	33
2016	26	30
2017	14	23
2018	3	6
2019	3	9
2020	2	8
2021	4	7
2022	1	5
2023	6	7
Total	140	202

MAUDE: Manufacturer and User Facility Device Experience.

Citation: Kumar VCS, Aloysius M, Aswath G. Adverse events associated with the gold probe and the injection gold probe devices used for endoscopic hemostasis: A MAUDE database analysis. World J Gastrointest Endosc 2024; 16(1): 37-43
URL: https://www.wjgnet.com/1948-5190/full/v16/i1/37.htm
DOI: https://dx.doi.org/10.4253/wjge.v16.i1.37

Kumar VCS, Aloysius M, Aswath G. Adverse events associated with the gold probe and the injection gold probe devices used for endoscopic hemostasis: A MAUDE database analysis. World J Gastrointest Endosc 2024; 16(1): 37-43 [PMID: 38313458 DOI: 10.4253/wjge.v16.i1.37]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.